Healthy, mtDNA-mutation free mesoangioblasts from mtDNA patients qualify for autologous therapy

Florence van Tienen, Ruby Zelissen, Erika Timmer, Marike van Gisbergen, Patrick Lindsey, Mattia Quattrocelli, Maurilio Sampaolesi, Elvira Mulder-den Hartog, Irenaeus de Coo, Hubert Smeets*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Healthy, mtDNA-mutation free mesoangioblasts from mtDNA patients qualify for autologous therapy'. Together they form a unique fingerprint.

Keyphrases

INIS

Biochemistry, Genetics and Molecular Biology